These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 129512)

  • 21. [A new anti-inflammatory agent: calcium bucloxate in pediatrics].
    Debray H; Galland A
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1440-2. PubMed ID: 4548650
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical experience with Riripen tablet (benzydamine hydrochloride) in otorhinolaryngology].
    Hayakawa A; Watanabe M; Konago M; Yoneyama H
    Jibiinkoka; 1968 Mar; 40(3):259-61. PubMed ID: 4877931
    [No Abstract]   [Full Text] [Related]  

  • 23. [A new nonsteroidal anti-inflammatory agent: bucloxic acid (804 CB)].
    Krausz F; Breliere JC; Vaillant J; Brunaud M; Navarro J
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1364-7. PubMed ID: 4480065
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experience with Chymar in otorhinolaryngology].
    Nagai T; Ushijima S; Furuichi N; Iwatake Y; Shiga K
    Jibiinkoka; 1967 Feb; 39(2):191-4. PubMed ID: 6070563
    [No Abstract]   [Full Text] [Related]  

  • 25. [Value of niflumic acid in otorhinolaryngology].
    Portmann M; Pardes P
    Rev Laryngol Otol Rhinol (Bord); 1968; 89(7):494-8. PubMed ID: 5715347
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of Elarzone-Dausse, a new E.N.T. anti-inflammatory agent].
    Ammar-Khodja A
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):665-6 passim. PubMed ID: 4280432
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anti-inflammatory agents in ORL diseases. Introduction].
    Passali D; Marcucci L
    Acta Otorhinolaryngol Ital; 1990; 10 Suppl 28():5-9. PubMed ID: 2248027
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical application of Apoplectal (drug affecting the peripheral circulation) in otorhinologic field].
    Mishima A
    Jibiinkoka; 1971 Mar; 43(3):257-62. PubMed ID: 5102070
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
    Lagrue G; Masbernard A; Giudicelli C; Hirbec G
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1434-9. PubMed ID: 4614821
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical testing with a new anti-inflammatory agent: diphenamide].
    Tafner G; Pedrazzoli M
    Clin Ter; 1977 Aug; 82(3):263-7. PubMed ID: 334450
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of clamoxyl (amoxicillin) in otorhinolaryngology and stomatology based on a clinical study of 90 cases].
    Brucker J; Massart F; Guérin J; Chaix G; Chevalier JG; Hannequin M
    Ann Otolaryngol Chir Cervicofac; 1975 Mar; 92(3):151-8. PubMed ID: 1217809
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical experimentation of calcium bucloxate (804 CB) in rheumatology].
    Louyot P; Tamisier JN; Pourel J
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1428-31. PubMed ID: 4614820
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical trial of Bactrim in otorhinolaryngology].
    Jacquemard C
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1971 Dec; 20(10):1171-2. PubMed ID: 4259894
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic experience in the use of Mebron tablet (DA-398) in otorhinolaryngologic field].
    Kono K; Sekine K
    Jibiinkoka; 1970 Sep; 42(9):711-3. PubMed ID: 5466086
    [No Abstract]   [Full Text] [Related]  

  • 35. [Preliminary study of the therapeutic action and tolerance of niflumic acid in pediatric otorhinolaryngology].
    Traissac L; Roche JC
    Rev Laryngol Otol Rhinol (Bord); 1977; 98(5-6):317-21. PubMed ID: 897412
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical trial of an antibiotic and decongestant combination: proxibron].
    Haguenauer JP; Bouchayer M; Jacquemard C
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Apr; 18(4):247-9. PubMed ID: 4249627
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacologic properties of a new, nonsteroidal anti-inflammatory agent, bucloxic acid (804 CB)].
    Navarro J; Stoliaroff M; Savy JM; Berny C; Brunaud M
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1368-78. PubMed ID: 4480066
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experimentation of LD 4644 in O.R.L].
    Decroix G; Desaulty A
    Lille Med; 1973 Nov; 18(9):1035-8. PubMed ID: 4603401
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical study of bumadizone calcium in otorhinolaryngology].
    Labayle J; Dumaine A
    Sem Hop; 1978 Feb; 54(4):231-4. PubMed ID: 208174
    [No Abstract]   [Full Text] [Related]  

  • 40. [Collu-Hextril in medico-surgical and otorhinolaryngologic medico-surgical treatment].
    Bensemmane ; Abdelouahab
    Rev Laryngol Otol Rhinol (Bord); 1970; 91(11):1043-6. PubMed ID: 5511158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.